Oxytocin

Oxytocin Nasal Spray is supplied by Crystal Peptides as a catalogued research material in the format nasal spray, 10mg/10ml. This catalogue presentation identifies the supplied format and labelled strength; it does not establish equivalence to materials used in published studies or to medicinal formulations.

Oxytocin is a naturally occurring nonapeptide involved in neuroendocrine signalling. Its molecular structure comprises nine amino-acid residues, a disulfide bridge between Cys1 and Cys6, and a C-terminal amide. Research examines oxytocin-receptor recognition, signalling pathways and social processing, with interpretation dependent on the experimental system, material characteristics and study context.

Chemical properties and registry information

These molecular identifiers describe oxytocin, not the complete spray formulation. They do not independently confirm the identity, composition or analytical characteristics of an individual catalogue batch.

Research background and published evidence

Published research

Published work includes peptide synthesis and structural characterisation, oxytocin-receptor recognition, receptor-binding assays and signalling studies. Oxytocin is also investigated in neuroendocrine and social-processing research. These areas use different experimental models, materials and outcome measures; molecular observations and behavioural findings therefore require separate interpretation rather than treatment as interchangeable evidence.

Social-processing research reports context-dependent results. Experimental tasks, participant characteristics and environmental conditions can influence interpretation. The literature should not be reduced to a general claim about bonding, trust or any other uniform behavioural outcome, and it does not establish such an outcome for this catalogue formulation.

Current scientific understanding

Oxytocin provides a defined molecular subject for studying relationships between peptide structure, receptor recognition and neuroendocrine signalling. However, a shared compound name does not demonstrate comparability across studies. Sequence, disulfide connectivity, terminal amidation, material composition and analytical methods remain relevant when evaluating published evidence. Findings involving related peptides or oxytocin analogues are not substitutes for evidence concerning the specified molecular entity.

Formulation note

The published research background largely concerns other research materials, formulations or routes rather than this exact catalogue presentation. Findings from injected or differently formulated material cannot be transferred to this nasal spray formulation. Excipients, formulation characteristics and experimental context may affect comparability; the labelled strength alone does not resolve those differences. No formulation-specific study results are supplied here.

Quality and testing

Quality assessment should rely on a batch-specific Certificate of Analysis (CoA) linked to the exact product and lot, together with the corresponding Safety Data Sheet (SDS). Review the reported methods, identity testing, peptide-content measurements and formulation information rather than inferring batch characteristics from registry entries or literature descriptions.

Chromatographic purity, molecular identity, peptide content and microbiological attributes are distinct measurements. A result for one attribute does not establish the others. Only tests documented for the matching batch should be treated as reported quality information; unspecified attributes remain unverified.

For laboratory research use only by qualified professionals. Not for human or veterinary use. No dosing directions are provided. Purchasers are responsible for compliance with applicable institutional and local requirements.